The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
or anywhere that actually gives a s hit.
grow up you effing pratt, you really think what is happening to howdens share price is because of what s hit you keep posting about, try having a look at most of the other companies in the uk and see what is happening to their share prices. You really are a prize brown w anker. I cant see what you think your acheiving , keep dissing and lying because you think your hard done by. No wonder ethnic minority people get slated with people like you preaching s hit.
Here we go again Mashpash the sh it stirrer.
Good on Howdens for supporting their manager for totally false accusations by a disgruntled employee.
If I remember rightly, the only letter that exists is his written warning for keep taking unauthorised time off, while his Asian relative was ill.
bet the bast ards didnt give you any interest though.
why dont you eff off mashpash, i suspect everybody on here is happy to be invested in howdens, all you do is keep sprouting the same old s h i t, youve obviously got a chip on your black/brown shoulder and I for one dont give two figs what your alleging.
divi paid thankyou.
Do you not think your brokers are mugging you all off, Ig paid mine at 8.30 tuesday morning, I dont believe they would have paid it out had they not had it in.
got mine this morning from IG.
https://www.theguardian.com/commentisfree/2022/jul/28/sadmin-mother-death-vodafone
good bit off publicity or not
I got out last monday at 1.31, took a hit of about -40% waited to long in hindsight but also better than what it is now,
it will of course go up big time now.
Smith+Nephew announces new UK R&D and manufacturing facility for Advanced Wound Management with $100m+ investment near Hull
09 June 2022 15:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220609:nPreqlMwJa&default-theme=true
Smith+Nephew announces new UK R&D and manufacturing facility for Advanced
Wound Management with $100m+ investment near Hull
PR Newswire
LONDON, June 9, 2022
LONDON, June 9, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN,NYSE:SNN), the
global medical technology business, today announces that it is to build a new
R&D and manufacturing facility for its Advanced Wound Management franchise on
the outskirts of Hull, UK.
Smith+Nephew will invest more than $100 million to create a world-class R&D,
manufacturing and flexible office environment. The development will also be
supported by a grant from UK Government. The new facility is expected to
support more than $10 billion of sales in its first ten years of operation.